Alnylam Pharmaceuticals
ALNY
#732
Rank
โ‚ฌ29.60 B
Marketcap
221,28ย โ‚ฌ
Share price
-1.04%
Change (1 day)
-41.97%
Change (1 year)
Alnylam Pharmaceuticals Inc. is a biopharmaceutical company focused on the R&D and commercialization of RNA interference (RNAi) therapeutics for genetically defined diseases.

We have found no dividend history for this company